APPLICATION
NDA010124
TYPE
NDA
ORIGINAL APPROVAL
1955-10-12
LATEST ACTION
1987-09-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
SERPALANDiscontinued
RESERPINE 0.25MG · TABLET · ORAL
SERPALANDiscontinued
RESERPINE 0.1MG · TABLET · ORAL
Approval history
1987-09-15Labeling · Supplement 6AP
1984-06-08Labeling · Supplement 5AP
1977-09-28Manufacturing (CMC) · Supplement 3 · standardAP
1955-10-12Type 5 - New Formulation or New Manufacturer · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.